Skip to Main Content
CWRU Links


Chris A.  Flask, PhD

Chris A. Flask, PhD

Associate Director for Shared Resources 216.844.4963 (o) 216.844.4987 (f)

Director, Imaging Resource Core Facility
Associate Professor, Radiology, Biomedical Engineering, and Pediatrics
Member, Cancer Imaging Program

Chris A. Flask, PhD, is the Associate Director for Shared Resources at Case Comprehensive Cancer Center and the Scientific Director of Imaging Research at Case Western Reserve University. He is also a tenured Associate Professor with 15 years of experience as an MRI physicist and expertise in rapid interventional MRI techniques and high field small animal MRI acquisitions. In 2007, he received a secondary appointment as Assistant Professor of Biomedical Engineering; in 2012, he received a secondary appointment as Assistant Professor of Pediatrics. Since 2013, he is Chair of the CWRU School of Medicine Core Steering Committee.

Dr. Flask received his degrees from CWRU many times. In 1992, he received a BS in chemical engineering. In 1999, he received his MS in chemical engineering and earned a PhD in biomedical engineering from CWRU in 2005. Other recognitions Dr. Flask has received include the Nobel Laureate Conference Invitational Award in 2001 and the Magnetic Resonance in Medicine – Reviewer with Distinction from 2012 to the present.


View Publications 

The goal of Flask’s research laboratory involves developing new quantitative MRI techniques as noninvasive biomarkers for patients dealing with nonalcoholic fatty liver disease and type II diabetes. Flask’s lab at the Imaging Research core is advancing and validating these biomarkers through preclinical and clinical MRI capabilities. Now, the laboratory research is on animal models but is expected to eventually be ready for clinical use. Using improved MRI techniques may make it possible to prevent advanced diseases like nonalcoholic fatty liver disease and type II diabetes by identifying problems early and with effective treatment.

MRI, MRI techniques, biomarkers, fatty liver disease, fatty liver, liver disease, liver, type II diabetes, imaging research, noninvasive biomarkers